Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,3,5-triazine-2,4-diamine, 6-(6-chloro-2-pyridinyl)-n2,n4-bis((1r)-2,2,2-trifluoro-1-methylethyl)-
2. 6-(6-chloro-2-pyridinyl)-n,n'-bis((2r)-1,1,1-trifluoro-2-propanyl)-1,3,5-triazine-2,4-diamine
1. 1644545-52-7
2. Ag-881
3. Vorasidenib [inn]
4. Vorasidenib [usan]
5. Ag881
6. 789q85ga8p
7. 6-(6-chloropyridin-2-yl)-2-n,4-n-bis[(2r)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine
8. 6-(6-chloropyridin-2-yl)-n2,n4-bis((r)-1,1,1-trifluoropropan-2-yl)-1,3,5-triazine-2,4-diamine
9. 1,3,5-triazine-2,4-diamine, 6-(6-chloro-2-pyridinyl)-n2,n4-bis((1r)-2,2,2-trifluoro-1-methylethyl)-
10. 6-(6-chloropyridin-2-yl)-n2,n4-bis[(2r)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine
11. 9uo
12. Pvm/ma
13. Ag-881; Vorasidenib
14. Vorasidenib (ag881)
15. Vorasidenib (ag-881)
16. Vorasidenib (usan/inn)
17. Vorasidenib [who-dd]
18. Unii-789q85ga8p
19. Ag 881 [who-dd]
20. Chembl4279047
21. Schembl16393139
22. Schembl22396621
23. Schembl23573057
24. Gtpl10663
25. Bdbm279948
26. Ex-a2574
27. Nsc803600
28. S8611
29. Us10028961, Compound 101
30. Who 10525
31. Akos037648888
32. Ccg-268824
33. Cs-8033
34. Nsc-803600
35. Ac-36152
36. Bs-15954
37. Hy-104042
38. A16908
39. C73178
40. D11834
41. 6-(6-chloropyridin-2-yl)-n~2~,n~4~-bis[(2r)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine
42. 6-(6-chloropyridin-2-yl)-n2,n4-bis((r)-1,1,1-trifluoro Propan-2-yl)-1,3,5-triazine-2,4-diamine
| Molecular Weight | 414.74 g/mol |
|---|---|
| Molecular Formula | C14H13ClF6N6 |
| XLogP3 | 5.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 5 |
| Exact Mass | 414.0794411 g/mol |
| Monoisotopic Mass | 414.0794411 g/mol |
| Topological Polar Surface Area | 75.6 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 448 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Vorasidenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vorasidenib, including repackagers and relabelers. The FDA regulates Vorasidenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vorasidenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vorasidenib supplier is an individual or a company that provides Vorasidenib active pharmaceutical ingredient (API) or Vorasidenib finished formulations upon request. The Vorasidenib suppliers may include Vorasidenib API manufacturers, exporters, distributors and traders.
Vorasidenib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vorasidenib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vorasidenib GMP manufacturer or Vorasidenib GMP API supplier for your needs.
A Vorasidenib CoA (Certificate of Analysis) is a formal document that attests to Vorasidenib's compliance with Vorasidenib specifications and serves as a tool for batch-level quality control.
Vorasidenib CoA mostly includes findings from lab analyses of a specific batch. For each Vorasidenib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vorasidenib may be tested according to a variety of international standards, such as European Pharmacopoeia (Vorasidenib EP), Vorasidenib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vorasidenib USP).
LOOKING FOR A SUPPLIER?
